Connection
Christopher Wardell to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications Christopher Wardell has written about TOR Serine-Threonine Kinases.
|
|
Connection Strength |
|
|
|
|
|
0.090 |
|
|
|
-
Boyd KD, Walker BA, Wardell CP, Ross FM, Gregory WM, Davies FE, Morgan GJ. High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma. Leuk Lymphoma. 2010 Nov; 51(11):2126-9.
Score: 0.090